SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030433
Filing Date
2019-08-08
Accepted
2019-08-08 08:11:27
Documents
43
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q evok-10q_20190630.htm 10-Q 1080873
2 EX-31.1 evok-ex311_10.htm EX-31.1 9588
3 EX-31.2 evok-ex312_8.htm EX-31.2 9868
4 EX-32.1 evok-ex321_6.htm EX-32.1 5041
5 EX-32.2 evok-ex322_9.htm EX-32.2 5212
  Complete submission text file 0001564590-19-030433.txt   3175641

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT evok-20190630.xml EX-101.INS 563649
7 XBRL TAXONOMY EXTENSION SCHEMA evok-20190630.xsd EX-101.SCH 30529
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20190630_cal.xml EX-101.CAL 16393
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20190630_def.xml EX-101.DEF 72025
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20190630_lab.xml EX-101.LAB 201383
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20190630_pre.xml EX-101.PRE 149716
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 191007558
SIC: 2834 Pharmaceutical Preparations